Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study
- DOI
- 10.1007/s40123-026-01448-4
- Published
- 2026-07-14
- Container
- Ophthalmology and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40123-026-01448-4,
title = {Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study},
author = {Filipe Mira and Sofia Donato and Fernanda Vaz and Filipa Madeira and Maria Picoto and António Mendes and João Beato and Sónia Torres-Costa and Carolina Pinto and Nuno Oliveira and Susana Feliciano and Miguel Lume and Rita Carreiro and Mariana Couto and Ângela Carneiro},
year = {2026},
journal = {Ophthalmology and Therapy},
doi = {10.1007/s40123-026-01448-4},
url = {https://doi.org/10.1007/s40123-026-01448-4}
}RIS
TY - JOUR TI - Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study AU - Filipe Mira AU - Sofia Donato AU - Fernanda Vaz AU - Filipa Madeira AU - Maria Picoto AU - António Mendes AU - João Beato AU - Sónia Torres-Costa AU - Carolina Pinto AU - Nuno Oliveira AU - Susana Feliciano AU - Miguel Lume AU - Rita Carreiro AU - Mariana Couto AU - Ângela Carneiro PY - 2026 JO - Ophthalmology and Therapy DO - 10.1007/s40123-026-01448-4 UR - https://doi.org/10.1007/s40123-026-01448-4 ER -
APA
Mira, F., Donato, S., Vaz, F., Madeira, F., Picoto, M., Mendes, A., Beato, J., Torres-Costa, S., Pinto, C., Oliveira, N., Feliciano, S., Lume, M., Carreiro, R., Couto, M., & Carneiro, Â. (2026). Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study. Ophthalmology and Therapy. https://doi.org/10.1007/s40123-026-01448-4
Source records
- crossref · retrieved 2026-09-27T06:57:17.315Z